Virtual Medicinal Product (VMP) - Antacid and Oxetacaine oral suspension
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Antacid and Oxetacaine oral suspension | Start Date 01-05-2013 | End Date |
Previous Name | Previous Name Generic Antacid & Oxetacaine oral suspension | Start Date 19-11-2008 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Free From
- null
- Name Basis
- Other
Codes
- ATC Code
- n/a
- BNF Codes
-
- BNF code 01010100
Code | Start Date | End Date |
---|---|---|
10147111000001108 | 06-03-2006 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Aluminium hydroxide | Based on Ingredient Substance | 40 mg | 1 ml | |
Magnesium hydroxide | Based on Ingredient Substance | 20 mg | 1 ml | |
Oxetacaine | Based on Ingredient Substance | 2 mg | 1 ml |
Name
Magnesium hydroxide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
1.0
Name
Oxetacaine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2.0
Strength and UOM (Dmr)
1.0
Name
Aluminium hydroxide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
40.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMNo Parent VTM
-
VMP(Current) Antacid and Oxetacaine oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 ml | 8 | Part VIIIB |
150 ml | ||
150 ml | 1593 | Part VIIIB |